{"organizations": [], "uuid": "e83b79b47b2f4eea7a3cd57744a459a71d9cd70e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180424.html", "section_title": "Archive News &amp; Video for Tuesday, 24 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mdxhealth-q1-operating-loss-widens/brief-mdxhealth-q1-operating-loss-widens-to-6-7-million-dollars-idUSFWN1S101D", "country": "US", "domain_rank": 408, "title": "BRIEF-Mdxhealth Q1 Operating Loss widens to 6.7 Million Dollars", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-24T13:12:00.000+03:00", "replies_count": 0, "uuid": "e83b79b47b2f4eea7a3cd57744a459a71d9cd70e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mdxhealth-q1-operating-loss-widens/brief-mdxhealth-q1-operating-loss-widens-to-6-7-million-dollars-idUSFWN1S101D", "ord_in_thread": 0, "title": "BRIEF-Mdxhealth Q1 Operating Loss widens to 6.7 Million Dollars", "locations": [], "entities": {"persons": [{"name": "mdxhealth", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " MDXHEALTH SA:\n* REG-MDXHEALTH PROVIDES FIRST QUARTER 2018\n* Q1 TOTAL REVENUE OF $9.7 MILLION, UP 50% FROM $6.5 MILLION IN Q1 2017\n* OPERATING LOSS OF $6.7 MILLION COMPARED TO $5.8 MILLION IN Q1 2017\n* Q1 PRODUCT REVENUE OF $7.9 MILLION, UP 60% FROM $4.9 MILLION IN Q1 2017\n* CASH AND CASH EQUIVALENTS OF $51.3 MILLION AS OF MARCH 31, 2018\n* DESPITE A STRONG Q1, WE DO NOT YET HAVE FULL VISIBILITY ON REVENUE PROJECTIONS GOING FORWARD - CEO\n* WE REMAIN CONFIDENT IN POSITIVE OUTLOOK FOR YEAR AND ACHIEVING HIGHER LEVELS OF TESTING VOLUME AND PRODUCT REVENUE COMPARED TO 2017 -CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-24T13:12:00.000+03:00", "crawled": "2018-04-25T14:28:30.000+03:00", "highlightTitle": ""}